{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:32:34Z","timestamp":1788888754359,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["274\/10-2"],"award-info":[{"award-number":["274\/10-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.yebeh.2016.01.032","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T13:07:51Z","timestamp":1456578471000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"PA","title":["Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures"],"prefix":"10.1016","volume":"57","author":[{"given":"Kathrin","family":"T\u00f6llner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Twele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.01.032_bb0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2016.01.032_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/epi.12296","article-title":"Issues related to development of new antiseizure treatments","volume":"54","author":"Wilcox","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0015","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.3390\/ijms140918284","article-title":"Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions","volume":"14","author":"Reddy","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneumeth.2015.03.025","article-title":"Which insights have we gained from the kindling and post-status epilepticus models?","volume":"260","author":"Gorter","year":"2015","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneumeth.2015.03.009","article-title":"Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration","volume":"260","author":"Levesque","year":"2015","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1528-1167.2008.01797.x","article-title":"Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models","volume":"50","author":"Blanco","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.eplepsyres.2013.09.014","article-title":"Pilocarpine-induced epilepsy in mice alters seizure thresholds and the efficacy of antiepileptic drugs in the 6-Hertz psychomotor seizure model","volume":"107","author":"Bankstahl","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2013.09.003","article-title":"The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs","volume":"77","author":"L\u00f6scher","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbr.2012.02.004","article-title":"Generation and characterization of pilocarpine-sensitive C57BL\/6 mice as a model of temporal lobe epilepsy","volume":"230","author":"Bankstahl","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"T\u00f6llner","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(25)22739-2","article-title":"The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid","volume":"271","author":"Finn","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0075","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/j.1460-9568.2012.08143.x","article-title":"Do proconvulsants modify or halt epileptogenesis? Pentylenetetrazole is ineffective in two rat models of temporal lobe epilepsy","volume":"36","author":"Rattka","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.025","article-title":"Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans","volume":"610","author":"L\u00f6scher","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0085","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.2042-7158.1989.tb06395.x","article-title":"A simple intravenous infusion method in rodents for determining the potency of anticonvulsants acting through GABAergic mechanisms","volume":"41","author":"Green","year":"1989","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1528-1157.1986.tb03572.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats","volume":"27","author":"Miller","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0920-1211(96)00022-8","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds","volume":"25","author":"L\u00f6scher","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-94-017-8914-1_22","article-title":"Epilepsy comorbidities: how can animal models help?","volume":"813","author":"Stafstrom","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-1211(91)90053-I","article-title":"Trans-2-en-valproate: reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs","volume":"9","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for antiepileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1528-1157.1981.tb06151.x","article-title":"Effects of some antiepileptic drugs in pentetrazol-induced convulsions in mice lesioned with kainic acid","volume":"22","author":"Czuczwar","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1528-1157.1982.tb05423.x","article-title":"Anticonvulsant action of phenobarbital, diazepam, carbamazepine, and diphenylhydantoin in the electroshock test in mice after lesion of hippocampal pyramidal cells with intracerebroventricular kainic acid","volume":"23","author":"Czuczwar","year":"1982","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0125","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected","volume":"17","author":"L\u00f6scher","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0130","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1528-1167.2009.02428.x","article-title":"Pattern of P450 expression at the human blood\u2013brain barrier: roles of epileptic condition and laminar flow","volume":"51","author":"Ghosh","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-1211(94)00070-D","article-title":"Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats","volume":"20","author":"Leite","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0140","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.0013-9580.2003.32803.x","article-title":"Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH\/NINDS\/AES models II workshop","volume":"44","author":"Stables","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2011.12.014","article-title":"Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy","volume":"234","author":"Bankstahl","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","article-title":"Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0165","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(97)00031-4","article-title":"Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1059-1311(03)00185-7","article-title":"Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models","volume":"13","author":"Sills","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0190","first-page":"57","article-title":"A study of the effects of lamotrigine on mice using two convulsive tests","volume":"53","author":"Getova","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.expneurol.2013.02.019","article-title":"The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains","volume":"247","author":"Watanabe","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yebeh.2015.06.011","article-title":"Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model","volume":"49","author":"Leclercq","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacology"},{"issue":"Suppl.1","key":"10.1016\/j.yebeh.2016.01.032_bb0210","first-page":"S32","article-title":"Opposing changes in neuronal excitability following an epileptogenic brain insult in mice and rats","volume":"387","author":"Br\u00f6er","year":"2014","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0920-1211(99)00095-9","article-title":"The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures","volume":"38","author":"L\u00f6scher","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0220","first-page":"203","article-title":"An overview of chronopharmacology","volume":"7","author":"Scheving","year":"1974","journal-title":"J Eur Toxicol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00340529","article-title":"Time \u2014 a key in experimental and practical medicine","volume":"36","author":"Mayersbach","year":"1976","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0230","first-page":"87","article-title":"Seasonal influences on biological rhythms of standardized laboratory animals","volume":"8","author":"Mayersbach","year":"1981","journal-title":"Chronobiologia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0235","series-title":"Circannual rhythms","author":"Gwinner","year":"1986"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/07420529409057227","article-title":"Seasonality of pineal melatonin production in the rat \u2014 possible synchronization by the geomagnetic field","volume":"11","author":"Bartsch","year":"1994","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0245","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.acthis.2010.08.005","article-title":"Comparative immunohistochemistry of synaptic markers in the rodent hippocampus in pilocarpine epilepsy","volume":"113","author":"K\u00e1roly","year":"2011","journal-title":"Acta Histochem"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","article-title":"Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures","volume":"123","author":"Volk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0260","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1167.2008.01916.x","article-title":"Complex time-dependent alterations in the brain expression of different drug efflux transporter genes after status epilepticus","volume":"50","author":"Kuteykin-Teplyakov","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0265","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1523\/JNEUROSCI.6616-10.2011","article-title":"A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood\u2013brain barrier","volume":"31","author":"Bankstahl","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2016.01.032_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501600055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501600055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:12:28Z","timestamp":1748776348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501600055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":54,"alternative-id":["S152550501600055X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.01.032","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the pentylenetetrazole seizure threshold test in epileptic mice as surrogate model for drug testing against pharmacoresistant seizures","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}